CBFβ Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression

Molecular Cell

Volumn 49, Issue 4, 2013, Pages 632-644

  Kim, Dong Young ^a,c   Kwon, Eunju ^a,c   Hartley, Paul D ^b,c   Crosby, David C ^b   Mann, Sumanjit ^b   Krogan, Nevan J ^b,c,d   Gross, John D ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GLADSTONE INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETERODIMER; HOLOENZYME; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CBF BETA; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; VIF PROTEIN;

ARTICLE; GENE CONTROL; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; IMMUNE SYSTEM; NONHUMAN; OLIGOMERIZATION; PROTEIN BINDING; REPORTER GENE; T LYMPHOCYTE;

AMINO ACID SEQUENCE; BASE SEQUENCE; CCAAT-BINDING FACTOR; CONSENSUS SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYTOSINE DEAMINASE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; PROTEIN STRUCTURE, QUATERNARY; T-LYMPHOCYTES; UBIQUITINATION; VIF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84874283933     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2012.12.012     Document Type: Article

References (51)

1. Albin J.S., Harris R.S. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev. Mol. Med. 2010, 12:e4.
2. Auclair J.R., Green K.M., Shandilya S., Evans J.E., Somasundaran M., Schiffer C.A. Mass spectrometry analysis of HIV-1 Vif reveals an increase in ordered structure upon oligomerization in regions necessary for viral infectivity. Proteins 2007, 69:270-284.
3. Bergeron J.R.C., Huthoff H., Veselkov D.A., Beavil R.L., Simpson P.J., Matthews S.J., Malim M.H., Sanderson M.R. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog. 2010, 6:e1000925.
4. Bullock A.N., Debreczeni J.E., Edwards A.M., Sundström M., Knapp S. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc. Natl. Acad. Sci. USA 2006, 103:7637-7642.
5. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., König R., et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5:e1000437.
6. Chang S.T., Sova P., Peng X., Weiss J., Law G.L., Palermo R.E., Katze M.G. Next-generation sequencing reveals HIV-1-mediated suppression of T cell activation and RNA processing and regulation of noncoding RNA expression in a CD4+ T cell line. MBio 2011, 2. e00134-e11.
7. Chen G., He Z., Wang T., Xu R., Yu X.-F. A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G. J. Virol. 2009, 83:8674-8682.
8. Collins A., Littman D.R., Taniuchi I. RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 2009, 9:106-115.
9. Daugherty M.D., D'Orso I., Frankel A.D. A solution to limited genomic capacity: using adaptable binding surfaces to assemble the functional HIV Rev oligomer on RNA. Mol. Cell 2008, 31:824-834.
10. Duda D.M., Borg L.A., Scott D.C., Hunt H.W., Hammel M., Schulman B.A. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 2008, 134:995-1006.
11. Frankel A.D., Young J.A. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 1998, 67:1-25.
12. Giri M.S., Nebozhyn M., Showe L., Montaner L.J. Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006. J. Leukoc. Biol. 2006, 80:1031-1043.
13. He Z., Zhang W., Chen G., Xu R., Yu X.-F. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction. J. Mol. Biol. 2008, 381:1000-1011.
14. He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J., Alber T., Zhou Q. HIV-1 Tat and host aff4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 2010, 38:428-438.
15. Huang X., Peng J.W., Speck N.A., Bushweller J.H. Solution structure of core binding factor beta and map of the CBF alpha binding site. Nat. Struct. Biol. 1999, 6:624-627.
16. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
17. Hultquist J.F., Binka M., LaRue R.S., Simon V., Harris R.S. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors. J. Virol. 2012, 86:2874-2877.
18. Hultquist J.F., McDougle R.M., Anderson B.D., Harris R.S. HIV Type 1 Viral Infectivity Factor and the RUNX Transcription Factors Interact with Core Binding Factor beta on Genetically Distinct Surfaces. AIDS Res Hum Retroviruses. 2012, 28:1543-1551.
19. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., et al. Global landscape of HIV-human protein complexes. Nature 2012, 481:365-370.
20. Jäger S., Kim D.Y., Hultquist J.F., Shindo K., LaRue R.S., Kwon E., Li M., Anderson B.D., Yen L., Stanley D., et al. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature 2012, 481:371-375.
21. Lee T.I., Johnstone S.E., Young R.A. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc. 2006, 1:729-748.
22. Li T., Chen X., Garbutt K.C., Zhou P., Zheng N. Structure of DDB1 in complex with a paramyxovirus V protein: viral hijack of a propeller cluster in ubiquitin ligase. Cell 2006, 124:105-117.
23. Li T., Robert E.I., van Breugel P.C., Strubin M., Zheng N. A promiscuous α-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat. Struct. Mol. Biol. 2010, 17:105-111.
24. Marcsisin S.R., Engen J.R. Molecular insight into the conformational dynamics of the Elongin BC complex and its interaction with HIV-1 Vif. J. Mol. Biol. 2010, 402:892-904.
25. Marcsisin S.R., Narute P.S., Emert-Sedlak L.A., Kloczewiak M., Smithgall T.E., Engen J.R. On the solution conformation and dynamics of the HIV-1 viral infectivity factor. J. Mol. Biol. 2011, 410:1008-1022.
26. McLean C.Y., Bristor D., Hiller M., Clarke S.L., Schaar B.T., Lowe C.B., Wenger A.M., Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 2010, 28:495-501.
27. Mehle A., Goncalves J., Santa-Marta M., McPike M., Gabuzda D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 2004, 18:2861-2866.
28. Mehle A., Thomas E.R., Rajendran K.S., Gabuzda D. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J. Biol. Chem. 2006, 281:17259-17265.
29. Melnikova I.N., Crute B.E., Wang S., Speck N.A. Sequence specificity of the core-binding factor. J. Virol. 1993, 67:2408-2411.
30. Paul I., Cui J., Maynard E.L. Zinc binding to the HCCH motif of HIV-1 virion infectivity factor induces a conformational change that mediates protein-protein interactions. Proc. Natl. Acad. Sci. USA 2006, 103:18475-18480.
31. Saha A., Deshaies R.J. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 2008, 32:21-31.
32. Shimizu H., Yokoyama S., Asahara H. Growth and differentiation of the developing limb bud from the perspective of chondrogenesis. Dev. Growth Differ. 2007, 49:449-454.
33. Smith J.L., Bu W., Burdick R.C., Pathak V.K. Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development. Trends Pharmacol. Sci. 2009, 30:638-646.
34. Stanley B.J., Ehrlich E.S., Short L., Yu Y., Xiao Z., Yu X.-F., Xiong Y. Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J. Virol. 2008, 82:8656-8663.
35. Stanley D.J., Bartholomeeusen K., Crosby D.C., Kim D.Y., Kwon E., Yen L., Caretta Cartozo N., Li M., Jäger S., Mason-Herr J., Hayashi F., et al. Inhibition of a NEDD8 Cascade Restores Restriction of HIV by APOBEC3G. PLoS Pathog. 2012, 8:e1003085. 10.1371/journal.ppat.1003085.
36. Stifani S., Ma Q. 'Runxs and regulations' of sensory and motor neuron subtype differentiation: implications for hematopoietic development. Blood Cells Mol. Dis. 2009, 43:20-26.
37. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
38. Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M., Kimura K., Shiina M., Sato K., Kumasaka T., Yamamoto M., et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell 2001, 104:755-767.
39. Tahirov T.H., Babayeva N.D., Varzavand K., Cooper J.J., Sedore S.C., Price D.H. Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 2010, 465:747-751.
40. Tang Y.Y., Shi J., Zhang L., Davis A., Bravo J., Warren A.J., Speck N.A., Bushweller J.H. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha. J. Biol. Chem. 2000, 275:39579-39588.
41. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002, 111:621-633.
42. Techtmann S.M., Ghirlando R., Kao S., Strebel K., Maynard E.L. Hydrodynamic and functional analysis of HIV-1 Vif oligomerization. Biochemistry 2012, 51:2078-2086.
43. Turro E., Lewin A., Rose A., Dallman M.J., Richardson S. MMBGX: a method for estimating expression at the isoform level and detecting differential splicing using whole-transcript Affymetrix arrays. Nucleic Acids Res. 2010, 38:e4.
44. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bories J.C., Alt F.W., Ryan G., et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 1996, 87:697-708.
45. Wong W.F., Kurokawa M., Satake M., Kohu K. Down-regulation of Runx1 expression by TCR signal involves an autoregulatory mechanism and contributes to IL-2 production. J. Biol. Chem. 2011, 286:11110-11118.
46. Xue B., Mizianty M.J., Kurgan L., Uversky V.N. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Cell Mol Life Sci. 2011, 69:1211-1259.
47. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 2003, 302:1056-1060.
48. Zhang W., Du J., Evans S.L., Yu Y., Yu X.F. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. Nature 2012, 481:376-379.
49. Zhen A., Wang T., Zhao K., Xiong Y., Yu X.F. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. J. Virol. 2010, 84:1902-1911.
50. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 2002, 416:703-709.
51. Zhou X., Evans S.L., Han X., Liu Y., Yu X.F. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components. PLoS ONE 2012, 7:e33495.